B. Riley Financial Surges 25% on Strong Q2 Earnings, Plus 19 Other Premarket Movers

MarketDash Editorial Team

9 hours ago

B. Riley Financial shares jumped 25% in premarket trading after posting a dramatic turnaround with Q2 earnings of $4.50 per share versus a year-ago loss. Here's a look at 20 stocks making significant moves before the opening bell.

B. Riley Financial Inc. (RILY) shares climbed sharply in premarket action Tuesday after the financial services firm delivered second-quarter results that marked a dramatic turnaround from last year's struggles.

The company reported earnings of $4.50 per share for the second quarter, a stark contrast to the year-ago loss of $14.35 per share. Revenue told an equally impressive story, more than doubling to $225.302 million from $94.885 million in the same period last year.

B. Riley Financial shares jumped 25% to $4.65 in the premarket session.

But B. Riley wasn't alone in making waves before the opening bell. Here's a rundown of other stocks showing significant movement in early trading.

Stocks Moving Higher

Biodexa Pharmaceuticals PLC-ADR (BDRX) led the gainers, surging 51.4% to $7.24 in premarket trading.

Venus Concept Inc (VERO) climbed 31.1% to $2.19 in premarket action, bouncing back after dropping over 10% on Monday.

Uniqure NV (QURE) extended its Monday gains, rising 14.1% to $23.30 in premarket trading after posting a 5% gain in the previous session.

Adagio Medical Holdings Inc (ADGM) gained 11.7% to $0.93 in premarket trading, recovering from Monday's 15% decline.

Sunrise New Energy Co Ltd (EPOW) rose 10.5% to $0.94 in premarket trading, also bouncing back from an 11% dip the previous day.

Socket Mobile Inc (SCKT) surged 10.3% to $1.29 in premarket action.

Rain Enhancement Technologies Holdco Inc (RAIN) shares jumped 10.1% to $6.65 in early trading.

Organogenesis Holdings Inc (ORGO) gained 9.3% to $5.29 in premarket trading after announcing it completed a planned Type-B meeting with the FDA, resulting in confirmation to initiate a rolling Biologics License Application for ReNu planned before the end of December.

Nektar Therapeutics (NKTR) rose 7.8% to $57.50 in premarket trading.

Stocks Moving Lower

Radiopharm Theranostics ADR (RADX) fell 39.8% to $6.40 in premarket trading. The sharp decline came after the stock jumped 150% on Monday following the company's announcement of interim RAD 101 Phase 2b clinical imaging trial data showing 92% concordance with MRI, the primary endpoint.

Saverone 2014 Ltd - ADR (SVRE) tumbled 37.8% to $2.20 in premarket trading after gaining 18% on Monday.

Zynex Inc (ZYXI) fell 36.6% to $0.42 in premarket trading, extending Monday's roughly 10% decline.

Immuron Ltd - ADR (IMRN) fell 23.8% to $0.74 in premarket trading after declining 5% on Monday.

iRobot Corp (IRBT) fell 23.2% to $0.90 in premarket trading. The stock plunged 73% on Monday after the company filed for Chapter 11 bankruptcy protection.

Envirotech Vehicles Inc (EVTV) dipped 17% to $0.93 in premarket trading.

Aldeyra Therapeutics Inc (ALDX) declined 15.7% to $3.36 in premarket trading. The company received a PDUFA extension for its Reproxalap NDA following an FDA request for a clinical study report.

Ascent Solar Technologies, Inc. (ASTI) shares dipped 15.1% to $3.54 in premarket trading after jumping 34% on Monday.

Lightwave Logic Inc (LWLG) dipped 14.5% to $3.22 in premarket trading after the company announced pricing of a $35 million public offering of common stock.

Fractyl Health Inc (GUTS) fell 10.4% to $2.00 in premarket trading.

Back to News